Načítá se...
Technetium-99 m radiolabeled paclitaxel as an imaging probe for breast cancer in vivo
The high incidence and mortality of breast cancer supports efforts to develop innovative imaging probes to effectively diagnose, evaluate the extent of the tumor, and predict the efficacy of tumor treatments while concurrently and selectively delivering anticancer agents to the cancer tissue. In the...
Uloženo v:
| Vydáno v: | Biomed Pharmacother |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5553547/ https://ncbi.nlm.nih.gov/pubmed/28222395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2017.02.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|